Division of Insurance Medicine
Sickness absence affects individuals, health care, insurance organizations, employers, and society. Nevertheless, the scientific knowledge base is very limited. We conduct research, systematic literature reviews, post graduate training, and networking regarding sickness absence, work disability, health, and living conditions.
New grant
Jurgita Narusyte has been granted 3,7 million SEK from AFA insurance to investigate whether part-time sick leave among private employees with mental disorders can prevent long-term sickness absence and contribute to more people remaining in work.
Conference on Mental Health and Work in Brussels
Professor Ellenor Mittendorfer-Rutz was invited by the Belgium government to speak at the high level conference on Mental Health and Work in Brussels. Professor Mittendorfer-Rutz outlined evidence-based strategies which can facilitate the entrance in the labour market of individuals with mental health complaints. The conference was organized as part of the Belgian presidency recognizing the challenge of taking action to combat psychosocial risks at work.
New grant
Emilie Friberg has been granted 4,6 million from FORTE for her research project entitled "Sustainable work strategies for people with multipel sclerosis".
New grant
Iman Alaie has been granted 2,4 million from the Swedish Research Council for his project entitled "Youth psychiatric disorders and the risk of labour market marginalisation".
New grant
Heidi Taipale has been granted 7 million SEK from Sigrid Juselius stifelse in Finland for her research project which addresses real-world effectiveness of complex pharmacotherapy regimens and their dose-response relationships for schizophrenia and possibilities to enhance it with genetic data.
New grants
Kristin Farrants and Alexis Cullen have been granted 3.0 million and 2.4 million respectively from The Swedish Research Council. Kristin Farrants received the grant for her project on morbidity among older women and men in paid work and Alexis Cullen for her project on early detection and intervention strategies regarding psychosis.
New study found no evidence of increase in risk of suicide
This new observational study is the first to examine suicides occurring during the early phase of the COVID-19 pandemic and finds that suicide numbers largely remained unchanged in the pandemic’s early months. However, the authors stress that governments must remain vigilant as the longer-term mental health and economic effects of the pandemic unfold and be poised to respond if the situation changes.
The study included around 70 authors from 30 countries who are members of the International COVID-19 Suicide Prevention Research Collaboration (ICSPRC).
Celebrating 5 years!
The field of Cochrane Insurance Medicine (CIM) was created by researchers from Switzerland, the Netherlands, Sweden and Canada for five years ago. Since then research in this field had increased in number of countries stimulated by the recognition of insurance medicine (IM) as a specialty with particular broad research needs. The aim of CIM is to make IM more evidence-based, promoting the production and use of scientific evidence to support IM practice. CIM has also become a platform for IM researchers and professionals to connect and collaborate.
Click here to read an article
Cochrane Insurance Medicine
Cochrane Insurance Medicine (CIM) has been established as a field within Cochrane.
CIM aims to establish and make evidence based knowledge regarding insurance medicine available for professionals and users.
The Division of Insurance Medicine has, together with groups from three other countries, worked since many years to establish this as a field within Cochrane.
Agreement on the new European Data Protection Legislation good for research
The European parliament, the Council of Ministers, and the European Commission have agreed on a common text which will replace national legislations on data protection by 2018 (PUL in Sweden).